Conference Banner

Obesity & Metabolic Disorders

Scientific Session

Obesity & Metabolic Disorders

Obesity & Metabolic Disorders:

Obesity and metabolic disorders are closely interlinked, forming a critical public health issue worldwide. Obesity, characterized by excessive fat accumulation, significantly increases the risk of developing metabolic disorders, such as type 2 diabetes, hypertension, dyslipidemia, and non-alcoholic fatty liver disease (NAFLD). These conditions collectively contribute to metabolic syndrome, which is a cluster of risk factors for cardiovascular disease and other health complications.

Understanding Obesity
Definition:
Obesity is generally defined by body mass index (BMI):
BMI ≥30 kg/m²: Obesity
BMI ≥25 kg/m² but <30 kg/m²: Overweight It also involves excess visceral fat that disrupts normal metabolic functions. Causes: Genetic: Heredity and genetic predisposition (e.g., FTO gene variants). Lifestyle: Poor diet, sedentary lifestyle, and high-calorie consumption. Environmental: Urbanization, lack of physical activity, and socioeconomic factors. Hormonal: Disruptions in appetite-regulating hormones like leptin, ghrelin, and insulin. Tracks: Insulin Resistance and Type 2 Diabetes Non-Alcoholic Fatty Liver Disease (NAFLD) Dyslipidemia and Cardiovascular Risk Metabolic Syndrome and Hypertension